Boston Scientific Corporation (BSX) SEC Filings & Earnings Calls

Leadership transition risk; uncertainty around strategic direction.

“CEO/CFO change can lead to strategic shifts or operational disruption.”

Loss of a key executive in MedSurg and Asia Pacific region; transition risk if senior advisor role does not ensure smooth handover

“Retirement of EVP and Group President, MedSurg and Asia Pacific; senior advisor role only through Feb 26, 2027”

Cybersecurity incident caused material operational disruption; full recovery timeline uncertain.

“cybersecurity incident that affected certain of its information technology systems and resulted in a global disruption to the Company’s operations” · word for word

Material impact on Q3 and FY2026 financial results; prior guidance withdrawn.

“likely to have a material impact on the Company’s results of operations for the third quarter and full year 2026” · word for word

Potential reputational damage and customer churn risk.

“impact of the incident on, and disruption to, the Company’s business, reputation and operations” · word for word

Cybersecurity incident leading to operational disruption, potential financial impact, and reputational risk.

“The incident has caused, and is expected to continue to cause, disruptions and limitations of access to certain of the Company’s information systems and business applications that support aspects of the Company’s operations, including the ability to process and ship customer orders.” · word for word

Acquisition integration risk

“The Penumbra acquisition is subject to FTC review and may not close as expected.”

Regulatory risk

“On March 16, 2026, we and Penumbra each received a request for additional information (Second Request) from the United States Federal Trade Commission (FTC) in connection with its review of the transaction.” · word for word

Liquidity risk

“Cash and cash equivalents decreased from $1,965M to $539M due to acquisitions and share repurchases.”

Foreign currency fluctuations impact reported growth, especially in EMEA and LACA.

“Impact of foreign currency fluctuations: EMEA -1.9%, LACA -6.2%”

Guidance raise may set high expectations for continued growth.

“Company raised FY2026 guidance, implying confidence but also higher bar.”

Execution risk: restructuring may disrupt operations or fail to achieve expected savings.

“If the Company’s underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially.” · word for word

Headcount reductions may impact employee morale and productivity.

“The Company does expect some headcount reductions to result from these restructuring activities.” · word for word

Investment is contingent on clinical and regulatory milestones; option may not be exercised, leading to forfeiture or reduction of equity stake.

“If Company does not exercise Call Option, equity interest will be forfeited or reduced by ~75%.”

ASR exposes company to stock price volatility; final share count depends on VWAP.

“Total number of shares that the Company will ultimately repurchase under the ASR will be determined based on the volume-weighted average price of the Company’s common stock during the term of the ASR.” · word for word

Acquisition Integration Risk

“Pending acquisition of Penumbra, Inc. for approximately $14.5 billion, subject to regulatory review and closing conditions.”

Regulatory Risk

“Second Request from FTC for Penumbra acquisition; transaction expected to close in second half of 2026.”

Foreign currency fluctuations impact reported growth; operational growth excludes FX.

“Operational net sales growth excludes impact of foreign currency fluctuations.”

Tariff exposure on imported goods

“Any modification of existing tariffs, or the introduction of new U.S. tariffs under alternative authorities, on imports from the countries where we do business for an extended period and without specific exemptions for our products... could have a material adverse impact on our financial condition, results of operations and cash flows.” · word for word

Tax incentive expiration

“Our manufacturing facilities in Costa Rica operate under the Free Trade Zone regime, and we also benefit from tax holidays and tax incentive grants in various other countries. Unless these incentives and grants are extended, they will expire between 2028 and 2034.” · word for word

Integration risks from acquisitions of Penumbra and Valencia Technologies.

“Announced agreement to acquire Penumbra, Inc.... Announced agreement to acquire Valencia Technologies Corporation.”

Discontinuation of ACURATE neo2/Prime aortic valve systems impacting prior year sales.

“management made the decision to discontinue worldwide sales of the ACURATE neo2™ and ACURATE Prime™ Aortic Valve Systems, which had prior year global sales of approximately $50 million per quarter.” · word for word

Integration risk: large acquisition ($14.5B) with complex product lines; potential for operational disruption or slower-than-expected synergy realization.

“Acquisition to expand Boston Scientific's cardiovascular portfolio... provides scaled entry into mechanical thrombectomy and neurovascular”

EPS dilution in first year: $0.06-0.08 dilutive to adjusted EPS; GAAP dilution higher due to amortization.

“expected to be $0.06-0.08 dilutive to adjusted earnings per share... The impact to GAAP earnings per share is expected to be dilutive in the first full year”

Integration risk: large acquisition ($14.5B) with complex product lines; potential for operational disruption or slower-than-expected synergy realization.

“Acquisition to expand Boston Scientific's cardiovascular portfolio... provides scaled entry into mechanical thrombectomy and neurovascular” · word for word

EPS dilution in first year: $0.06-0.08 dilutive to adjusted EPS; GAAP dilution higher due to amortization.

“expected to be $0.06-0.08 dilutive to adjusted earnings per share... The impact to GAAP earnings per share is expected to be dilutive in the first full year” · word for word

Leadership transition risk due to departure of a director or principal officer.

“Item 5.02 departure of a director or principal officer.”

Supply chain disruption

“The impact of disruptions in the supply of the materials and components used in manufacturing our products or the sterilization of our products” · word for word

Tariff impact

“Impacts from changing U.S. trade policies and newly introduced tariffs, and any countermeasures or other reactions by other countries thereto” · word for word